Astrotech Corp balance sheet
At the end of fiscal 2026, Astrotech Corp had total assets of $20.5m, total liabilities of $4.3m and shareholders' equity of $16.2m. It held $8.4m in cash against $0 of debt: net cash of $8.4m.
Balance sheet
| Fiscal year | 2011Jun 2011 | 2012Jun 2012 | 2013Jun 2013 | 2014Jun 2014 | 2015Jun 2015 | 2016Jun 2016 | 2017Jun 2017 | 2018Jun 2018 | 2019Jun 2019 | 2020Jun 2020 | 2021Jun 2021 | 2022Jun 2022 | 2023Jun 2023 | 2024Jun 2024 | 2025Jun 2025 | 2026Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 15 | 10 | 5 | 4 | 2 | 4 | 2 | 1 | 2 | 3 | 36 | — | — | — | 3 | 8 |
| Receivables | 2 | 2 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | — | — | — | 0 | 1 | 0 | 0 | 0 | — | — | — | — | — | — | — | — |
| Total current assets | 18 | 13 | 11 | 6 | 33 | 23 | 14 | 4 | 3 | 5 | 65 | 55 | 45 | 35 | 22 | 16 |
| Total assets | 58 | 50 | 48 | 41 | 44 | 31 | 19 | 5 | 4 | 6 | 66 | 56 | 48 | 38 | 27 | 21 |
| Accounts payable | 1 | 3 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 |
| Deferred revenue (current) | 11 | 3 | 1 | 1 | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — |
| Total current liabilities | 13 | 8 | 7 | 10 | 2 | 2 | 2 | 1 | 1 | 4 | 4 | 3 | 3 | 3 | 2 | 2 |
| Short-term debt | 0 | 0 | 0 | 6 | — | — | — | — | — | — | — | — | — | — | — | — |
| Long-term debt | 6 | 6 | 6 | — | 0 | 0 | 0 | 0 | — | 0 | — | — | — | — | — | — |
| Total debt | 7 | 6 | 6 | 6 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 20 | 14 | 13 | 10 | 2 | 2 | 2 | 1 | 1 | 5 | 4 | 3 | 3 | 3 | 5 | 4 |
| Shareholders' equity | 38 | 36 | 35 | 29 | 41 | 29 | 17 | 4 | 3 | 1 | 61 | 53 | 45 | 35 | 22 | 16 |
| Non-controlling interests and other (assets − liabilities − equity) | — | — | — | 2 | — | — | — | — | — | — | — | — | — | — | — | — |
| Net debt (negative = net cash) | −8 | −4 | 1 | 2 | −2 | −4 | −2 | −1 | −2 | −3 | −35 | — | — | — | −3 | −8 |
| Shares outstanding | — | — | — | — | — | — | — | — | — | — | — | 2m | 2m | 2m | 2m | 2m |
| Quarter | 2025 Q1Sept 2024 | 2025 Q2Dec 2024 | 2025 Q3Mar 2025 | 2025 Q4Jun 2025 | 2026 Q1Sept 2025 | 2026 Q2Dec 2025 | 2026 Q3Mar 2026 | 2026 Q4Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
| Total current assets | 32 | 28 | 25 | 22 | 18 | 14 | 11 | 16 |
| Total assets | 34 | 31 | 27 | 27 | 23 | 20 | 16 | 21 |
| Accounts payable | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
| Total current liabilities | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
| Total liabilities | 2 | 3 | 3 | 5 | 4 | 4 | 4 | 4 |
| Shareholders' equity | 32 | 28 | 25 | 22 | 19 | 16 | 12 | 16 |
| Shares outstanding | 2m | 2m | 2m | 2m | 2m | 2m | 2m | 2m |
Compare with peers
- Quantum-si Inc balance sheet
- Bionexus Gene Lab Corp balance sheet
- YD Bio Ltd balance sheet
- Ispecimen Inc. balance sheet
- Seer, Inc. balance sheet
Head to head: ASTC vs QSIASTC vs BGLCASTC vs YDES
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies